Prominent German pharmaceutical cannabis wholesaler and manufacturer, operating an asset-light model, seeks €1 million investment to expand into telehealth and drive further growth.

With a strong track record in GMP-certified production and distribution, this company is poised for significant advancement and offers a unique opportunity for strategic partnership.

Listing ID: 22327924509
Licence(s) Held: GDP Distribution Licence, EU-GMP Certification (Product Release), MedCanG Cannabis License, Wholesale License for Active Substances Used in Medicinal Products

Seeking strategic equity partner to invest €1 million for continued growth and expansion

Listing Details:

Established German cannabis importer, manufacturer, and wholesaler of pharmaceutical-grade medical cannabis products, adhering to GDP and EU-GMP standards

Built as an asset-light model, outsourcing warehousing and logistics to a seasoned pharmaceutical logistics partner

Offers unique products with a dedicated customer base, the company benefits from a skilled sales team and strategic partnerships with major global cannabis market players

Imports high-quality products from cultivators and partners with extraction facilities in Portugal, Spain, Denmark, and Canada, while ensuring swift market entry through regulatory expertise

With over 700 pharmacies served and substantial growth since April, the company plans to expand into new markets like Portugal through joint ventures with local cultivators

In 2023, the company generated over €800k in revenue, with forecasts indicating a rise to €1.5 million by the end of 2024 and achieving profitability by Q1 2025

Established supply agreements/contracts in place with major players in the global cannabis market

Company is developing a telemedicine platform to boost market reach and profitability, with anticipated financial benefits in 2025

Seeks strategic equity partner to invest €1 million to facilitate product introduction, secure exclusive contracts, expand sales, and enter the Portuguese market

Company is valued at $5 million pre-investment and is open to discussions for a majority takeover of 51%+ ownership